CC
RMD icon

Centiva Capital’s ResMed RMD Stock Holding History

Centiva Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,338
Closed -$300K – 2165
2026
Q1 		$300K Buy
+1,338
New +$333K ﹤0.01% 1064
2025
Q1 		– Sell
-978
Closed -$224K – 2047
2024
Q4 		$224K Buy
+978
New +$235K ﹤0.01% 1312
2024
Q3 		– Sell
-6,380
Closed -$1.22M – 2531
2024
Q2 		$1.22M Buy
+6,380
New +$1.29M 0.02% 671
2023
Q4 		– Sell
-15,431
Closed -$2.28M – 2178
2023
Q3 		$2.28M Buy
15,431
+5,625
+57% +$1.02M 0.05% 346
2023
Q2 		$2.14M Buy
+9,806
New +$2.19M 0.05% 357
2023
Q1 		– Sell
-5,305
Closed -$1.1M – 1784
2022
Q4 		$1.1M Buy
+5,305
New +$1.17M 0.03% 534
2022
Q1 		– Sell
-5,227
Closed -$1.36M – 1781
2021
Q4 		$1.36M Buy
+5,227
New +$1.36M 0.03% 482
2020
Q1 		– Sell
-2,232
Closed -$346K – 872
2019
Q4 		$346K Buy
+2,232
New +$322K 0.02% 531

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Centiva Capital's RMD Position: Q2 2026 in Review

Centiva Capital sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,338 shares — an estimated $300K sold.

Centiva Capital first reported a position in RMD in Q4 2019 and held it in 8 quarters. The position peaked at $2.28M in Q3 2023. 885 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Centiva Capital reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 1,338 ResMed shares in Q2 2026, an estimated $300K.
  • Centiva Capital first reported a position in ResMed in Q4 2019 and held it in 8 quarters.
  • Centiva Capital's ResMed position peaked at $2.28M in Q3 2023.
  • 885 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.